The prospective multi-centre BIO-LivIQ trial will enrol 325 patients across 60 sites worldwide.

The placement device for the LivIQ leadless pacemaker. [Image courtesy of Biotronik] Biotronik today announced the initiation ...

International BIO-LivIQ Study Will Generate Evidence for Global LivIQ Leadless Pacemaker Approvals; Far-Field Sensing and ...

(RTTNews) - Abbott Laboratories (ABT) a biopharmaceutical major, announced on Wednesday that it has received FDA approval for its dual chamber (DR) leadless pacemaker system dubbed AVEIR. As per the ...

Wireless or leadless pacemakers, commonly implanted in adults, may be a safe and effective short-term option for children with slow heartbeats, according to new research published today in Circulation ...

This story is part of a series on the current progression in Regenerative Medicine. This piece discusses the regeneration of the cardiovascular system. In 1999, I defined regenerative medicine as the ...

Pediatric cardiologists have implanted a dual chamber leadless pacemaker in a child. UC Davis Director of Pediatric Electrophysiology Dan Cortez has set another world record: He is the first to ...

ABBOTT PARK, Ill., Nov. 12, 2021 /PRNewswire/ -- Abbott (NYSE: ABT) today announced new, late-breaking data from the global Leadless II IDE study evaluating Abbott's investigational Aveir leadless ...

This week Cambridge Consultants unveiled a semi-leadless pacemaker it designed for start-up EBR Systems. The device, called Wireless Cardiac Stimulation system (WiCS), includes a leadless electrode ...

Every year more than one million people receive a pacemaker. Until now, leadless versions were only available for 20% of these patients. However, thanks to an international consortium led by Amsterdam ...

A prototype for a leadless pacemaker that converts the heart's oscillations into voltage generated 10.9% of the energy needed to stimulate one heartbeat in a laboratory benchtop experiment. If the ...